Stay Current With CID4

Stay up to date on the
latest news from CID4.


CID4 Twitter Feed


Quarterly Newsletters

The CID4 Report Vol. I No. I The CID4 Report Vol. I No. I (2765 KB)

View All

Blog Topics

Sophono Named Colorado Company to Watch Finalist

Congratulations to Sophono for being named a 2012 Colorado Company to Watch, Finalist, by the Colorado Office of Economic Development & International Trade. The Boulder-based, commercial-stage medical device company is focused on abutment-free bone anchored conduction hearing devices. Learn more about the great strides Sophono is making [HERE]. 

CID4 is pleased to see its partnership with Sophono progress as we continue to execute upon our mission to advance the Colorado bioscience ecosystem through company creation and job growth. The Sophono team, led by CEO Jim Kasic, is driving the economic development of Colorado while bringing to market critical advances in and new options for those suffering from hearing loss. Since CID4’s original participation, Sophono raised significant investment capital, received FDA clearance to market their Alpha1(m) device, increased full-time hires and evolved from a development-stage to commercial entity with the initiation of product sales. 

Colorado Companies to Watch energizes the state of Colorado by recognizing companies that are developing valuable products and services, creating quality jobs, enriching communities and creating new industries throughout the state. These companies fuel the economic fire of Colorado by accounting for much of the economic growth and economic independence of individuals throughout the state. In order to be eligible for nomination these companies must possess attributes such as: being privately-held, Colorado headquartered, growth focused, with 6-99 full-time equivalent employees, have sales of $750,000 to $50 million, and demonstrate the intent and capacity to grow based on evidence such as: employee or sales growth, exceptional entrepreneurial leadership, sustainable competitive advantage or other notable factor(s) that showcase the company’s success. 

This unique awards program produces a multitude of benefits for all stakeholders. Participating companies have the opportunity to gain increased visibility in local and state communities as well as to improve stakeholder relationships and contribute to a dynamic business environment. Citizens have increased access to rewarding income opportunities and are able to build pride in innovative and valuable entrepreneurial companies, and the state of Colorado is able to showcase trend-setting leaders in diverse entrepreneurial fields that strengthen the state's economy. 

You are cordially invited to attend the 4th Annual, Colorado Companies to Watch Gala Awards Dinner, Friday 22 June at the Denver Marriott City Center. Additional details and purchase tickets [HERE].
Comments

CID4 Seeks Graduate Interns for 2011/2012 Academic Calendar

UPDATE | The Application Deadline Has Been Extended to COB Monday 7 November

CID4 is now seeking graduate student interns for the remaining 2011/2012 academic calendar.

Graduate interns will have an opportunity to be involved in many aspects of business development, implementation and program activities while providing key support to management and staff. Additionally, all CID4 interns share responsibilities for administrative tasks that keep the office running smoothly and ensure top quality program support. In a busy professional setting, candidates must be good team players, know how to prioritize tasks and manage their time well. Expect to allocate a minimum of ten-hours per week to your internship.

Under the supervision of senior management, the CID4 graduate intern(s) will assist in the construction of a competitive intelligence virtual library that may ultimately function as an important shared resource for the entire Colorado bioscience ecosystem. In addition, assistance with research and due diligence, and other development projects are required.

To receive the application packet forward your resume to arubenstein@cid4.com

Application deadline for 2011/2012 academic calendar appointments is October 31.

Download job description here.


Comments

All Portfolio Companies Accepted to Present at the 2011 Rocky Mountain Life Science Investor and Partnering Conference

All four CID4 portfolio companies, Sophono, PeptiVir, VetDC and Flashback Technologies, have been accepted to present and participate in partnering discussions at the 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC).

Organized by the Colorado BioScience Association, the RMLIPC is the Rocky Mountain region’s premiere investor and partnering conference, attracting venture capital funds, corporate venture funds and business development leaders from the largest global biopharmaceutical and medical device companies – all convening in Denver, CO September 21-23, 2011. The conference incorporates a robust and competitive company selection process that is filtered by a national committee of life science investors and business development executives. The selection committee recently released names of the thirty companies hand-picked to attend and present over the course of the three-day conference.

CID4’s mission to advance the Colorado bioscience ecosystem through company creation and job growth is only partially fulfilled through project investment, it is the active management role that yields tangible progressive milestone-driven value, such as architecting early-stage company roadmaps and assisting in the raising of follow-on capital. Positioning a portfolio company in front of institutional capital and potential industry partners is a critical function played by CID4 management. Having Sophono, PeptiVir, VetDC and Flashback Technologies participate speaks to the quality of technologies emerging from Colorado and validates the CID4 project selection process which is driven by the industry professionals who generously volunteer their time and expertise as members of CID4’s Technical and Business Advisory Committee.”

“Our Association spearheads the investor and partnering conference every other year for the region. This is our second event, and we have been absolutely thrilled at the response from both companies applying to present and investors desiring to attend,” said Holli Riebel, President and CEO of the Colorado BioScience Association. “The selection of four CID4 Project companies to present at this year’s conference is a reflection of CID4’s role as more than just a source of investment capital, but also an active participant in the management of its Project companies.” Comments

August 5th: Submission Date for New Project Consideration

CID4 is seeking its fifth project. A review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration. Material may be submitted HERE

CID4 recently launched a new website where business plans of all shapes and sizes are submitted online on a rolling basis. The new CID4 Innovation Database is proving to be a powerful tool, enabling industry partners and investors from all over world to reach into the technology-rich Colorado life science ecosystem. Providing an efficient, single point of entry, the database has been warmly received by both commercial partners and institutional investors and is being validated as an effective tool for catalyzing significant opportunities for Colorado entrepreneurs. Companies or technology business plans that had been uploaded to the CID4 Innovation Database were presented at the intense partnering and investor conferences C21 BioVentures in Napa, CA in May and BIO 2011 in Washington, D.C. in June. 

Those companies and technologies who submit their content by the August 5th cut-off will be considered for review by management and the Technical and Business Advisory Committee (TBAC). For more details about the project selection process visit HERE. Rolling submissions received following the August 5th cut-off will be considered in the next project evaluation session, date announcement forthcoming. 

CID4 has committed $1.25 million to four projects, which have created 22 direct jobs and raised an additional $1.3 million of investment capital. CID4 is delivering on its mission of Economic Development through Innovation Advancement.

Comments